Showing posts with label Enzogenol. Show all posts
Showing posts with label Enzogenol. Show all posts
Tuesday, September 24, 2013
'Clot Picker' Rescues tPA Stroke Failures
Well, tPA is a failure most of the time anyway, only a 12% full success rate. So who the hell is finding something better?
Saturday, November 3, 2012
Question to StrokeSmart magazine
They were asking for article ideas and this was mine. I'm sure they won't do anything about it.
Where are we in the US about hyperacute therapies like Draculin, edaravone from Japan, enzognel from New Zealand? What should doctors be giving patients in the first days? fish oil?, statins?, anti-depressants? nitric oxide? ibuprofen? ceria nanoparticles? leg compressions? music? MMP-9? minocycline? levodopa? Honokiol? amantadine? melatonin? If you don't know about all of these you are pathetic.
Dear dean,
And yes, I know I'm dammed arrogant, these are all documented in postings in my blog. Ask your countries stroke association about these or your doctor and watch them sputter.
Where are we in the US about hyperacute therapies like Draculin, edaravone from Japan, enzognel from New Zealand? What should doctors be giving patients in the first days? fish oil?, statins?, anti-depressants? nitric oxide? ibuprofen? ceria nanoparticles? leg compressions? music? MMP-9? minocycline? levodopa? Honokiol? amantadine? melatonin? If you don't know about all of these you are pathetic.
Dear dean,
Last week, I sent you an important survey that National Stroke
Association developed to help us in preparation for our relaunch of StrokeSmart™
magazine. If you haven’t already taken it, please take a few minutes to tell us more about your needs.
Thank you for your feedback. Your
information will shape the future of StrokeSmart magazine.
Sincerely,
Taryn Fort
Director, Marketing and Communications
Director, Marketing and Communications
And yes, I know I'm dammed arrogant, these are all documented in postings in my blog. Ask your countries stroke association about these or your doctor and watch them sputter.
Saturday, October 27, 2012
Guideline -Diagnosis and treatment of ischemic stroke.
From National Guideline Clearinghouse - Agency for Healthcare Research and Quality.
Guideline -Diagnosis and treatment of ischemic stroke.
This is absolutely pathetic, written in 2001, updated in June 2010, currently being updated again. Does not have any hyperacute therapies like the following;
1. liposome-encapsulated hemoglobin written in Feb. 2010
2. bat saliva - Draculin written in May, 2011, up to 9 hours
3. cardiac glycosides written in Feb. 2006 - up to 6 hours
4.inhalation of nitric oxide written in March, 2012 - 48 hours to 7 days
5. 5. 5. Nitric oxide written in 2006, to be tested in humans yet.
6. xenon gas written in Feb. 2006, to be tested yet
7. caffeinol irish coffee injection written in April 2003 to be tested in humans
8. Docosahexaenoic acid (DHA), a component of fish oil written in Nov. 2010, up to 5 hours
9. nicotine written in July 2005, to be tested in humans
10. Viagra written in 2002, to be tested in humans, for 7 days
11. PSD-95 inhibitors written in 2012, tested in monkeys 3 hours
11. Enzogenol written in Nov. 2011 for New Zealand
12 edaravone approved in Japan since 2001
13. nitroglycerin instructions
14. benzodiazepine inverse agonist written in Nov. 2010
Don't listen to me I have no medical standing at all.
Saturday, November 19, 2011
Pine-bark extract helps brain function
Can we get this added to our list of possible drug therapies?
http://www.stuff.co.nz/dominion-post/news/national/6000084/Pine-bark-extract-helps-brain-function
Ronny Franks has spent the past year battling to regain her memory after suffering a traumatic brain injury when she tripped and hit her head on a wooden floor.
The Auckland woman, like thousands of others in New Zealand, suffers the daily frustrations of trying to remember what she did yesterday, trying to sleep with issues such as ringing in her ears, and learning to live with the difficulties and fears of a brain injury.
"I can't remember anything, not even what I did yesterday. I'll go to the cupboard and I can't remember why or what I want. It's frustrating and scary."
Franks, 64, a former Air New Zealand assistant accountant, was one of 60 people who were recently involved in a study to test the effectiveness on brain injury of a supplement containing New Zealand pine bark extract.
The study, by a team of AUT University researchers, headed by Professor Valery Feigin, the director of AUT's National Institute for Stroke and Applied Neuroscience, and Dr Alice Theadom, found the antioxidant and anti-inflammatory effects of the extract meant people were three times more likely to recover their everyday memory than those who took a placebo.
Enzogenol, the name of the supplement, is a natural extract from the bark of New Zealand-grown pines.
The aim of the study was to explore its effectiveness in improving verbal and working memory, information processing speed, attention span, everyday memory difficulties and post-concussive symptoms in patients three to 12 months after a mild traumatic brain injury.
Theadom said the preliminary results indicated an improvement in day-to-day cognitive functioning.
"There was a significant improvement on the reporting of cognitive failures such as walking into a room and forgetting what you went in for, failure to remember names, forgetting directions on a familiar route, and forgetting to respond to correspondence."
Franks said the difference she noticed during the study was amazing. Each time she was interviewed she had to sit a random memory test, where she was asked to recall 20 items. When she started she could remember only the last four, but as the trial wore on she was able to remember all 20 each time.
"I was happy, I felt different – I felt very positive, I could just remember everything."
Feigin said 90 New Zealanders suffered a brain injury every day, including stroke, and traumatic brain injury was a leading cause of disability and death, costing the health system an estimated $100 million a year. There are now plans for a full clinical trial.
http://www.stuff.co.nz/dominion-post/news/national/6000084/Pine-bark-extract-helps-brain-function
Ronny Franks has spent the past year battling to regain her memory after suffering a traumatic brain injury when she tripped and hit her head on a wooden floor.
The Auckland woman, like thousands of others in New Zealand, suffers the daily frustrations of trying to remember what she did yesterday, trying to sleep with issues such as ringing in her ears, and learning to live with the difficulties and fears of a brain injury.
"I can't remember anything, not even what I did yesterday. I'll go to the cupboard and I can't remember why or what I want. It's frustrating and scary."
Franks, 64, a former Air New Zealand assistant accountant, was one of 60 people who were recently involved in a study to test the effectiveness on brain injury of a supplement containing New Zealand pine bark extract.
The study, by a team of AUT University researchers, headed by Professor Valery Feigin, the director of AUT's National Institute for Stroke and Applied Neuroscience, and Dr Alice Theadom, found the antioxidant and anti-inflammatory effects of the extract meant people were three times more likely to recover their everyday memory than those who took a placebo.
Enzogenol, the name of the supplement, is a natural extract from the bark of New Zealand-grown pines.
The aim of the study was to explore its effectiveness in improving verbal and working memory, information processing speed, attention span, everyday memory difficulties and post-concussive symptoms in patients three to 12 months after a mild traumatic brain injury.
Theadom said the preliminary results indicated an improvement in day-to-day cognitive functioning.
"There was a significant improvement on the reporting of cognitive failures such as walking into a room and forgetting what you went in for, failure to remember names, forgetting directions on a familiar route, and forgetting to respond to correspondence."
Franks said the difference she noticed during the study was amazing. Each time she was interviewed she had to sit a random memory test, where she was asked to recall 20 items. When she started she could remember only the last four, but as the trial wore on she was able to remember all 20 each time.
"I was happy, I felt different – I felt very positive, I could just remember everything."
Feigin said 90 New Zealanders suffered a brain injury every day, including stroke, and traumatic brain injury was a leading cause of disability and death, costing the health system an estimated $100 million a year. There are now plans for a full clinical trial.
Subscribe to:
Posts (Atom)